Diego de Miguel‐Pérez
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
- MicroRNA in disease regulation 9
- Breast Cancer Treatment Studies 7
- Oncology top 5%
- Cancer Cells and Metastasis 9
- Cancer Immunotherapy and Biomarkers 7
- Cancer Treatment and Pharmacology 5
-
- Extracellular vesicles in disease 10
-
- Lung Cancer Treatments and Mutations 13
- Co-authors
- María José SerranoFrancisco G. OrtegaChristian RolfoJosé A. LorenteAlessandro RussoAlba Rodríguez‐MartínezJosé Luis García PucheM. Carmen Garrido-Navas
- Journals
- Critical Reviews in Oncology/Hematology (5 papers)Journal of Clinical Oncology (4 papers)Scientific Reports (3 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Diego de Miguel‐Pérez
57 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 574
- Oncology 457
- Molecular Biology 589
- Pulmonary and Respiratory Medicine 271
- Immunology 97
Countries citing papers authored by Diego de Miguel‐Pérez
This map shows the geographic impact of Diego de Miguel‐Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego de Miguel‐Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego de Miguel‐Pérez more than expected).
Fields of papers citing papers by Diego de Miguel‐Pérez
This network shows the impact of papers produced by Diego de Miguel‐Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego de Miguel‐Pérez. The network helps show where Diego de Miguel‐Pérez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Diego de Miguel‐Pérez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 26 | |
| 7 | 2022 | 42 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 92 | |
| 11 | 2019 | 57 | |
| 12 | 2019 | 31 | |
| 13 | 2019 | 2 | |
| 14 | 2019 | 157 | |
| 15 | 2019 | 9 | |
| 16 | 2019 | 21 | |
| 17 | 2015 | 35 | |
| 18 | 2012 | 13 | |
| 19 | 2012 | 10 | |
| 20 | 2009 | 16 |
About Diego de Miguel‐Pérez
Diego de Miguel‐Pérez is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Cancer Genomics and Diagnostics (11 papers), Extracellular vesicles in disease (10 papers), MicroRNA in disease regulation (9 papers), Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Breast Cancer Treatment Studies (7 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Cancer Research (574 citations), Oncology (457 citations) and Molecular Biology (589 citations). Diego de Miguel‐Pérez has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include María José Serrano, Francisco G. Ortega, Christian Rolfo, José A. Lorente, Alessandro Russo, Alba Rodríguez‐Martínez, José Luis García Puche, M. Carmen Garrido-Navas, José L. García-Puche and Hugh Ilyine. Their work appears in journals such as Critical Reviews in Oncology/Hematology, Journal of Clinical Oncology, Scientific Reports, Cancer and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.